Fertility and sterility · 2026
The VILOCITY trial: validating incubators in the lab, optimizing culture and investigating blastulation yield, a randomized control trial.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vessa Blake, Barrett Francesca, Pangasnan Rosanna, Noriega Pablo Guzman, Garrido Nicolás, Whitehead Christine, Seli Emre, Werner Marie, Molinaro Thomas
Аннотация
OBJECTIVE: To determine whether using a benchtop incubator for embryo culture improves blastulation rates compared with a conventional box incubator.
DESIGN: Prospective split-cohort double-blind randomized control trial (RCT) at a single academic-affiliated center.
SUBJECTS: Patients undergoing in vitro fertilization with preimplantation genetic testing for aneuploidy and planning a subsequent frozen single euploid embryo transfer were recruited between December 2023 and January 2025.
INTERVENTION: The primary exposure was culture in a benchtop incubator. Patients with ≥4 metaphase II (MII) oocytes at the time of vaginal oocyte retrieval were randomized. Retrieved MII oocytes were allocated by block randomization in a 1:1 ratio, with half cultured in the benchtop incubator and half in a conventional box incubator. All other embryology procedures, media, and developmental checkpoints were standardized between groups.
MAIN OUTCOME MEASURES: The primary outcome was blastulation rate per MII oocyte. Secondary outcomes included fertilization rate, blastulation rate per 2-pronuclear (2PN) embryo, embryo grade and morphology, and ploidy rates. Clinical outcomes after subsequent frozen euploid embryo transfer were also assessed, including ongoing pregnancy rate (OPR), pregnancy loss, and live birth rate (LBR).
RESULTS: A total of 2,152 MII oocytes from 145 patients were randomized and included in the primary analysis. Blastulation rate per MII was identical between box and benchtop incubators (51% vs. 51%). Fertilization rate (84% vs. 86%), blastulation rate per 2PN (61% vs. 59%), and euploid rate (69% vs. 66%) were also comparable between groups. Embryo grading did not differ by incubator, including day of blastulation, expansion grade, inner cell mass grade, or trophectoderm grade. Among 133 frozen embryo transfers (69 box, 64 benchtop), pregnancy outcomes were comparable between groups. Ongoing pregnancy rate was 67% in the box group vs. 64% in the benchtop group. Pregnancy loss (biochemical and clinical) occurred in 9% vs. 20%, and LBR was 67% vs. 61%, respectively.
CONCLUSION: In this RCT, culture in a benchtop incubator did not improve blastulation rate per MII compared with a conventional box incubator. Other embryologic and pregnancy outcomes were also comparable between incubator types, indicating that when other variables are controlled, the incubator alone does not meaningfully influence outcomes.
TRIAL REGISTRATION NUMBER: NCT06214936, Study Details | NCT06214936 | Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield | ClinicalTrials.gov.
DESIGN: Prospective split-cohort double-blind randomized control trial (RCT) at a single academic-affiliated center.
SUBJECTS: Patients undergoing in vitro fertilization with preimplantation genetic testing for aneuploidy and planning a subsequent frozen single euploid embryo transfer were recruited between December 2023 and January 2025.
INTERVENTION: The primary exposure was culture in a benchtop incubator. Patients with ≥4 metaphase II (MII) oocytes at the time of vaginal oocyte retrieval were randomized. Retrieved MII oocytes were allocated by block randomization in a 1:1 ratio, with half cultured in the benchtop incubator and half in a conventional box incubator. All other embryology procedures, media, and developmental checkpoints were standardized between groups.
MAIN OUTCOME MEASURES: The primary outcome was blastulation rate per MII oocyte. Secondary outcomes included fertilization rate, blastulation rate per 2-pronuclear (2PN) embryo, embryo grade and morphology, and ploidy rates. Clinical outcomes after subsequent frozen euploid embryo transfer were also assessed, including ongoing pregnancy rate (OPR), pregnancy loss, and live birth rate (LBR).
RESULTS: A total of 2,152 MII oocytes from 145 patients were randomized and included in the primary analysis. Blastulation rate per MII was identical between box and benchtop incubators (51% vs. 51%). Fertilization rate (84% vs. 86%), blastulation rate per 2PN (61% vs. 59%), and euploid rate (69% vs. 66%) were also comparable between groups. Embryo grading did not differ by incubator, including day of blastulation, expansion grade, inner cell mass grade, or trophectoderm grade. Among 133 frozen embryo transfers (69 box, 64 benchtop), pregnancy outcomes were comparable between groups. Ongoing pregnancy rate was 67% in the box group vs. 64% in the benchtop group. Pregnancy loss (biochemical and clinical) occurred in 9% vs. 20%, and LBR was 67% vs. 61%, respectively.
CONCLUSION: In this RCT, culture in a benchtop incubator did not improve blastulation rate per MII compared with a conventional box incubator. Other embryologic and pregnancy outcomes were also comparable between incubator types, indicating that when other variables are controlled, the incubator alone does not meaningfully influence outcomes.
TRIAL REGISTRATION NUMBER: NCT06214936, Study Details | NCT06214936 | Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield | ClinicalTrials.gov.